Stockreport

OS Therapies Initiates Commercial-ready Manufacturing of OST-HER2 to Support Anticipated Biologics Licensing Authorization (BLA) Filing [Yahoo! Finance]

OS Therapies Incorporated  (OSTX) 
PDF Business Wire Fri, February 14, 2025 at 1:36 PM GMT+1 3 min read In This Article OSTX NEW YORK, February 14, 2025 BUSINESS WIRE )--OS Therapies, Inc. (NYSE-A: [Read more]